Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials

BACKGROUND: Sacubitril/valsartan and angiotensin-converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) therapies were reported to affect glycaemic control and the development of diabetes mellitus (DM), but the findings are inconsistent. We examined the evidence for the effects of sac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ruxin, Ye, Haowen, Zhao, Yongting, Wei, Jinjing, Wang, Ying, Zhang, Xiaofang, Wang, Lihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758945/
https://www.ncbi.nlm.nih.gov/pubmed/36527023
http://dx.doi.org/10.1186/s12916-022-02682-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758945/
https://www.ncbi.nlm.nih.gov/pubmed/36527023
http://dx.doi.org/10.1186/s12916-022-02682-w

Ejemplares similares